Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
squamous cancer
Pharma
BMS's Opdivo-Yervoy flunks test in squamous head and neck cancer
BMS's Opdivo/Yervoy combo has excelled versus several tumor types. But the treatment failed in a phase 3 trial pitting it against Extreme in SCCHC.
Kevin Dunleavy
Jul 16, 2021 11:26am
Are Regeneron's Libtayo hopes 'hubris' or can it rule I-O?
Nov 6, 2019 11:21am
Roche's Tecentriq comes up short in squamous lung cancer
Sep 10, 2019 1:00pm
Merck rains on Roche's parade with double Keytruda win
May 23, 2018 12:35pm
